Jupiter Life Line Hospitals (JLHL) Q3 25/26 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 25/26 earnings summary
2 Feb, 2026Executive summary
Dombivli hospital, a 500-bed facility, was completed ahead of schedule and on budget, with phased opening starting at 200 beds and full operations expected by mid-February 2026.
Pune South project construction has begun, Mira Road project is under regulatory approval, and Bibwewadi (Pune) is in early construction with CapEx under INR 50 crore so far.
Existing hospitals show steady operating momentum, with no major operational surprises except for the impact of the new labor code.
Consolidated revenue from operations for Q3 FY26 was ₹3,653.67 million, up from ₹3,328.07 million in Q3 FY25; nine-month revenue reached ₹11,119.49 million, up from ₹9,657.41 million year-over-year.
Net profit for Q3 FY26 stood at ₹424.98 million, compared to ₹522.16 million in Q3 FY25; nine-month net profit was ₹1,439.20 million, down from ₹1,484.72 million year-over-year.
Financial highlights
Q3 FY26 total income: INR 366.5 crore, up 9.8% year-over-year; EBITDA: INR 83.4 crore, up 9.2% year-over-year; EBITDA margin: 22.8%.
Q3 FY26 PAT: INR 42.5 crore, down 18.7% year-over-year, impacted by a one-time labor code provision of INR 6.4 crore.
9M FY26 total income: INR 1,111.9 crore, up 15.1% year-over-year; EBITDA: INR 254 crore, up 15.2% year-over-year; EBITDA margin: 22.8%.
9M FY26 PAT: INR 143.9 crore, down from INR 148.5 crore year-over-year, also impacted by labor code changes.
Q3 ARPOB: INR 68,000; Q3 occupancy: 61.4%.
Outlook and guidance
Dombivli hospital expected to be EBITDA negative for the first two years, with break-even anticipated by end of year two.
Consolidated margins will face drag from Dombivli for the next couple of years; mature hospitals expected to maintain margins, Indore to see incremental margin improvement.
Total bed capacity expected to increase from 1,048 to approximately 2,500 with upcoming projects.
ARPOB for mature assets expected to grow in line with inflation; new hospitals to see faster ARPOB growth in early years.
The group continues to monitor regulatory developments regarding the new labour codes and will adjust accounting as needed.
Latest events from Jupiter Life Line Hospitals
- Q1 FY25 saw strong revenue, profit, digital accreditation, and capacity expansion.JLHL
Q1 24/253 Feb 2026 - Strong revenue and profit growth, with major expansion and capital investment underway.JLHL
Q2 24/253 Feb 2026 - Double-digit growth, strong ARPOB, and major expansions, with margin dilution from new hospitals.JLHL
Q2 25/2619 Dec 2025 - FY25 saw strong growth, a recommended dividend, and major expansion and restructuring.JLHL
Q4 24/2519 Dec 2025 - Q1 FY26 revenue and EBITDA rose, but PAT declined on higher costs; volumes and ARPOB up.JLHL
Q1 25/2619 Dec 2025 - Strong growth and expansion, with new hospitals funded by internal accruals and no new debt.JLHL
Q3 24/2519 Dec 2025